Which statements are true about Schedule II controlled substance prescriptions?

Which statements are true about Schedule II controlled substance prescriptions?

• A. They can be dispensed without checking central profile.
• B. They can be handwritten or computer generated but must be signed in ink; no allowable refills; BD, FL name and address must be on the script before scanning; check central profile for last fill and brand/generic; if too early for a refill, inform patient and do not dispense; double count pills and initials on the bottle and label the back of the script after filling.
• C. They can have multiple refills and do not require signature in ink.
• D. They do not require name and address.

Answer: (B)

Schedule II prescriptions are tightly regulated because these substances have a high potential for abuse. They must be written or computer-generated but require a signature in ink, and they have no allowable refills. The script must include the patient’s name and address and the prescriber’s information, and it should be scanned only after confirming these details. Before dispensing, you must check the central profile to verify the last fill and whether the medication should be given as brand or generic, and if it’s too early for a refill, you inform the patient and do not dispense. After filling, you double-count the pills, place your initials on the bottle, and label the back of the script. These steps collectively ensure proper authorization, tracking, and safety.

Schedule II prescriptions are tightly regulated because these substances have a high potential for abuse. They must be written or computer-generated but require a signature in ink, and they have no allowable refills. The script must include the patient’s name and address and the prescriber’s information, and it should be scanned only after confirming these details. Before dispensing, you must check the central profile to verify the last fill and whether the medication should be given as brand or generic, and if it’s too early for a refill, you inform the patient and do not dispense. After filling, you double-count the pills, place your initials on the bottle, and label the back of the script. These steps collectively ensure proper authorization, tracking, and safety.